White Paper on Cut Point Determination for ADA Data and Auditing of Pharmacokinetic Large Molecule Method Validation

White Paper on Cut Point Determination for ADA Data and Auditing of Pharmacokinetic Large Molecule Method Validation
October 2, 2022 Ariadne Solutions

Artificial intelligence empowered Red Thread® helped KCAS Bioanalytical and Biomarker Services achieve higher throughput, consistent outcomes, objective analysis, and net return on investment of 20.5 and 13.6 for cut point determination of ADA data and auditing of large molecule method validation data for pharmacokinetic studies respectively.

To learn more, download our white paper “Artificial Intelligence increases efficiencies and reduces bias for bioanalytical pharmacokinetic studies and anti-drug antibody statistical determinations”